Category: Home

Anti-angiogenesis potential of natural compounds

Anti-angiogenesis potential of natural compounds

Next, cell cycle analysis was performed to gain insight Anti-angiogenesis potential of natural compounds the mechanism of action Anti-angiogenesia Anti-angiogenesis potential of natural compounds cell growth inhibition of SK-MEL-5 Liver care essentials cells. Cell Prolif 54 Anti-anigogenesis :e Kim MH, Jeong YJ, Cho HJ, Hoe HS, Park KK, Park YY, et al. Angiogenesis targeting therapies trigger treatment resistance as a result of plasticity of the tumor microenvironment [ 10 ], upregulation of pro-angiogenic factors[ 16 ], recruitment of pro-angiogenic cells[ 17 ], and increased pericyte coverage[ 18 ].

Video

Introduction to Cancer Biology (Part 4): Angiogenesis

Anti-angiogenesis potential of natural compounds -

The present article focuses on products that have a high degree of anti-angiogenic activity, but it also describes some of the many other actions of these agents that can inhibit tumour progression and reduce the risk of metastasis.

The herbs that are traditionally used for anticancer treatment and that are anti-angiogenic through multiple interdependent processes including effects on gene expression, signal processing, and enzyme activities include Artemisia annua Chinese wormwood , Viscum album European mistletoe , Curcuma longa curcumin , Scutellaria baicalensis Chinese skullcap , resveratrol and proanthocyanidin grape seed extract , Magnolia officinalis Chinese magnolia tree , Camellia sinensis green tea , Ginkgo biloba, quercetin, Poria cocos, Zingiber officinalis ginger , Panax ginseng, Rabdosia rubescens hora Rabdosia , and Chinese destagnation herbs.

Quality assurance of appropriate extracts is essential prior to embarking upon clinical trials. More data are required on dose—response, appropriate combinations, and potential toxicities. Given the multiple effects of these agents, their future use for cancer therapy probably lies in synergistic combinations.

During active cancer therapy, they should generally be evaluated in combination with chemotherapy and radiation. In this role, they act as modifiers of biologic response or as adaptogens, potentially enhancing the efficacy of the conventional therapies.

keywords 32 Biomedical and Clinical Sciences Oncology and Carcinogenesis Cancer Complementary and Integrative Health Genetics Nutrition Prevention. To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.

Gacche RN , Meshram RJ. Prog Biophys Mol Biol , 2 , 15 Oct Cited by: 49 articles PMID: Parmar D , Apte M. Eur J Pharmacol , , 16 Mar Cited by: 34 articles PMID: Wahl O , Oswald M , Tretzel L , Herres E , Arend J , Efferth T , Efferth T. Curr Med Chem , 18 21 , 01 Jan Cited by: 38 articles PMID: Marmé D.

Onkologie , 24 Suppl , 01 Feb Cited by: 3 articles PMID: Zhao Y , Adjei AA. Oncologist , 20 6 , 22 May Cited by: articles PMID: PMCID: PMC Review Free full text in Europe PMC. Contact us. Europe PMC requires Javascript to function effectively. Recent Activity. Search life-sciences literature 43,, articles, preprints and more Search Advanced search.

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy. Abstract Available from publisher site using DOI. A subscription may be required.

Shanmugam MK 1 ,. Warrier S 2 ,. Kumar AP 3 ,. Sethi G 1 ,. Arfuso F 4. Affiliations 1. Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore Authors Shanmugam MK 1 Sethi G 1. Division of Cancer Stem Cells and Cardiovascular Regeneration, Manipal Institute of Regenerative Medicine, Manipal University, Bangalore Authors Warrier S 2.

Cancer Science Institute of Singapore, National University of Singapore, Singapore Authors Kumar AP 3. Stem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, WA Authors Arfuso F 4.

Share this article Share with email Share with twitter Share with linkedin Share with facebook. Abstract Background Neovascularization, also known as angiogenesis, is the process of capillary sprouting from pre-existing blood vessels.

This physiological process is a hallmark event in normal embryonic development as blood vessels generally supply both oxygen and nutrients to the cells of the body.

Any disruption in this process can lead to the development of various chronic diseases, including cancer. In cancer, aberrant angiogenesis plays a prominent role in maintaining sustained tumor growth to malignant phenotypes and promoting metastasis. The leakiness in the tumor microvasculature is attributed to the tumor cells migrating to distal site organs and forming colonies.

Methods In this article, we briefly review the various mediators involved in the angiogenic process and the anti-angiogenic potential of selected natural compounds against various malignancies.

Natural products represent a rich diversity of compounds for drug discovery and are currently being actively exploited to target tumor angiogenesis.

Conclusion Agents such as curcumin, artemisinin, EGCG, resveratrol, emodin, celastrol, thymoquinone and tocotrienols all have shown prominent anti-angiogenic effects in the preclinical models of tumor angiogenesis.

Several semi-synthetic derivatives and novel nano-formulations of these natural compounds have also exhibited excellent anti-angiogenic activity by increasing bioavailability and delivering the drugs to the sites of tumor angiogenesis.

Smart citations by scite. ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.

Explore citation contexts and check if this article has been supported or disputed. Extracellular vesicles remodel tumor environment for cancer immunotherapy. Yue M , Hu S , Sun H , Tuo B , Jia B , Chen C , Wang W , Liu J , Liu Y , Sun Z , Hu J Mol Cancer , 22 1 , 13 Dec Cited by: 0 articles PMID: PMCID: PMC Review Articles in the Open Access Subset are available under a Creative Commons license.

The Role of Natural Extracts in the Management of Infantile Hemangiomas and Vascular Tumors. Roca IC , Cojocaru E , Rusu CD , Trandafir LM , Săveanu CI , Lupu VV , Butnariu LI , Ţarcă V , Moscalu M , Bernic J , Lupu A , Ţarcă E Pediatric Health Med Ther , , 06 Jan Cited by: 0 articles PMID: PMCID: PMC Review Articles in the Open Access Subset are available under a Creative Commons license.

Anti angiogenic food components: can be a major source of bias in the investigation of angiogenesis inhibitors. Rastmanesh R , Bowirrat A , Gupta A , Gilley E , Blum K Ann Transl Med , 11 12 , 23 Oct Cited by: 0 articles PMID: PMCID: PMC Review Articles in the Open Access Subset are available under a Creative Commons license.

Ferroptosis as a potential target for cancer therapy.

McMaster Experts is powered by VIVO. Natural appetite suppressant navigation. Anti-angiogenesis potential of natural compounds Kf Departments Research About Login. abstract An integrative approach for ntural a patient with cancer should target the multiple biochemical and physiologic pathways that support tumour development and minimize normal-tissue toxicity. Angiogenesis is a key process in the promotion of cancer. Many natural health products that inhibit angiogenesis also manifest other anticancer activities.

Anti-angiogenesis potential of natural compounds -

Moreover, recent literature has demonstrated that a variety of pro-angiogenic factors VEGF, angiopoietin-1, bFGF have the ability of inhibiting EC apoptosis 4 in tumor angiogenesis.

Natural products isolated from plants have been used as medicine from ancient times. The discovery of natural products for treatment dated back to BC in Mesopotamia 5.

Traditional Chinese medicine TCM and Indian Ayurveda system are well documented over thousands of years. Early experiments have verified their properties of anti-inflammatory, anti-allergic and anti-infectious diseases 6 , 7. Natural phytochemicals have been applied to the therapy of various diseases, including tumors 8.

These phytochemicals can effectively inhibit the initiation, development and progression of neoplasm by regulating cellular proliferation, apoptosis and metastasis 9. Recent studies have indicated the important roles of natural compounds in modulating tumor angiogenesis by promoting the apoptosis of endothelial cell and inhibiting the angiogenesis-associated cytokines In this review, we recapitulate the process of tumor angiogenesis and present some natural products that have the effect of anti-tumor angiogenesis.

A systematic literature search was conducted in PubMed database from to There were no language restrictions, and the abstracts of the papers identified by the initial search were evaluated by the lead reviewer Peng Song for appropriateness to this review.

The inclusion criteria of references was that the abstracts of the references introduced the molecular mechanism investigation of natural products against tumor angiogenesis through in vitro or in vivo experiments.

The function of an extensive vascular network is to supply nutrients and oxygen and remove metabolic waste. During early embryogenesis, vascular growth is the results of combination of vasculogenesis and angiogenesis Vasculogenesis refers to that new blood vessels are formed from primitive ECs precursors, as opposed to angiogenesis, in which the blood vessels developed from pre-existing ECs in established vessels In adulthood, new blood vessels are rarely formed except in several physiological or pathological processes such as female reproductive cycling and wound healing.

The sprouting, migration and proliferation of ECs are regulated by various cytokines, among them VEGF is a pivotal one At the early stage of neoplasm events, tumors present a balance between cell apoptosis and cell proliferation Tumor cells produce pro-angiogenic factors, such as VEGF, PDGF and anti-angiogenic factors, such as angiostatin and thrombospondin.

However, once the average volume of a tumor exceeds mm 3 , insufficient supply of oxygen and nutrients to tumor tissues will occur. At this state, hypoxia inducible factor 1 alpha HIF1-α is able to bind to hypoxia-regulators and induce the production of VEGF and other pro-angiogenic factors Oncogene Ras and the mutated tumor suppressor gene TP53 also mediate this pro-angiogenic effect.

The synthesis of anti-angiogenic factors are found decreased in these tumors In turn, the growth of neoplasm tissues promotes the initiation of angiogenesis The most well-known receptors for tumor angiogenesis on the membrane of endothelial cells are tyrosine kinase receptors with their co-receptor, neuropilin.

These receptors bind to VEGF or bFGF. The transcription of several pro-angiogenic factors can be initiated by the second messenger cascade of these receptors. High levels of VEGF can be found in most tumor types 1 , VEGF exerts the key role in the formation of new blood vessels and the proliferation of ECs.

There are three tyrosine kinase receptors of VEGF, VEGFR-1 to VEGFR-2 is the most prominent receptor in angiogenesis, which binds to VEGFA with strong tyrosine kinase activity Moreover, latent forms of VEGF ligands are separated in the extracellular matrix, that are regulated by the release and activation of extracellular matrix-degrading proteases e.

The up-regulation of other pro-angiogenic signals, such as FGF family, is involved in sustaining tumor angiogenesis 3 , Besides the VEGF signaling pathway, other signaling pathways and associated factors are involved in tumor angiogenesis.

Angiopoietin 1 ANGPT1 and ANGPT2 are important ligands from the ANGPT family, that bind to the receptor tyrosine kinase TIE2 on the membrane of ECs. Since ANGPT1 acts as an agonist of TIE2, its function is to promote vessel maturation. The activation of TIE2 mediated by ANGPT2 can induce vascular disruption and increase angiogenesis Another important system that regulates tumor angiogenesis is the Notch-Notch-ligand system.

Endothelial-specific ligand Delta-like 4 DLL4 mediates the formation of the tip and stalk cells following VEGF stimulation Apparently, neovasculature is strongly governed by ECs apoptosis. Both proangiogenic growth factors and extracellular matrix ECM act as the key roles in EC survival and angiogenesis 4.

Induction of angiogenic growth factors and associated pathways are capable of inhibiting ECs apoptosis. For instance, ECs sustainment has been demonstrated to be linked with the modulation of cell apoptosis by VEGF By increasing the expression of anti-apoptotic proteins, such as Bcl-2 and survivin, bFGF is able to decrease ECs apoptosis, which guarantees the cells survival Regarding the role of cell matrix and cell-cell interactions in angiogenesis, the anti-apoptotic effect of VEGF is dependent on the regulation of αvβ3-integrin and VE-cadherin protein 27 , Since the pivotal role of ECs in angiogenesis, many natural products are developed to target EC apoptosis.

For example, resveratrol is able to increase Gly-LDL-induced vascular endothelial cell apoptosis Similarly, Physalis alkekengi L. extract can reduce the apoptosis of ECs after exposing to hyperglycemia Overall, angiogenic factors secreted by tumor cells Figure 1 and EC apoptosis Figure 2 are of significance in triggering and processing vessel formation in tumor microenvironment.

Figure 1 Primary principles of angiogenesis in tumor microenvironment. Several significant regulators VEGF, FGF, MMPs, TIE2 and related pathways are involved in tumor angiogenesis. Figure 2 ECs apoptosis can be regulated by pro-angiogenic factors in tumor angiogenesis.

After secreting a variety of cytokines VEGF, bFGF, Angiopoietin-1 , tumor cells exerts the role of anti-apoptosis in ECs by binding to its receptors. Up-regulated expression of anti-apoptotic proteins BCL-2, A1, IAP, etc and protein kinases Akt, Erk, etc can be found in ECs, which results in more survival and less apoptosis in ECs.

Vasculature has been explored for many decades and the application of in vitro and in vivo assays to evaluate the induction and inhibition of vascularization has exerted a significant role for researchers to study and understand angiogenesis The well-established in vitro models, such as the model of ECs, are easily analyzed and reproducible, yet the cells become senescent in the culture after a few passages Unlike the in vitro models, in vivo models, for example, the model of chick chorioallantoic membrane CAM , owns the advantages of short experimental period and low cost, which is available for drug screening As an ideal anti-tumor angiogenesis model, zebrafish has been widely used in drug screening due to its small size, transparent embryos, easy large-scale rearing, strong reproductive capacity and short experimental period The aortic ring test is a model of angiogenesis based on organ culture.

In this model, the molecular mechanism in regulating angiogenesis can be clarified, but it cannot truly reflect the microvascular environment of tumor growth Another widely used in vivo model is xenograft tumor in mice. Of note, tumor angiogenic environment in animals is different from human, so assays in animals could not replace that in human We have summarized the advantages and disadvantages of the current common angiogenesis models both in vitro and in vivo , which will provide clues for human cancer study Table 1.

Table 1 Properties of common experimental models of angiogenesis in vivo and in vitro. Polyphenols are members of a large family of chemical compounds with several phenolic groups, that can be found in foods and beverages of plant origin, including the spices, dried herbs, tea, red wine, coffee, cocoa products, seeds and nuts, vegetables, and fruits.

Polyphenols are usually classified as phenolic acids, flavonoids, stilbenes, lignans, secoiridoids, among others. Polyphenols are of significance in the sustainment of human health.

Recent studies have illustrated the pharmacologic functions of polyphenols that include antioxidation, vascular wall protection, improving enterogastric digestion, promoting immune response, and prevention of chronic disorders, such as tumor, atherosclerosis, hypertension, diabetes and so on.

In addition to the summary of the chemical structures of polyphenols Figure 3 , the effect of several polyphenols Ellagic acid, Chlorogenic acid, Quercetin, Catechin, Baicalin, Delphinidin, 6-methoxyequol, et al.

on tumor angiogenesis have also been studied in recent years Table 2. Ellagic acid can inhibit angiogenesis by inhibiting the expression of VEGFR2 in ECV cell line.

Chlorogenic acid is one of the hydroxygenic acid derivatives, which derives from Eucommia ulmoides Oliv. Quercetin, a flavanol-like compound, is derived from Quercus iberica. Catechin is a flavanol-like compound and derived from black tea, which can affect angiogenesis by inhibiting VEGF Baicalin, originated from Scutellaria baicalensis Georgi , can also inhibit tumor angiogenesis by regulating VEGFR As for Delphinidin, it regulates angiogenesis by affecting the expression of HIF-1α and VEGF in A cells Figure 3 The chemical structures of polyphenols involved in tumor angiogenesis.

Table 2 Natural anti-tumor angiogenesis polyphenols and their sources, experimental models and anti-angiogenic mechanisms. Polysaccharides are polymeric carbohydrate macromolecules, that are composed of long-chain monosaccharide units connected by glycosidic bonds.

As pivotal bioactive macromolecules, polysaccharides are mainly extracted from plants, animals and microorganisms. Polysaccharides are currently applied to various biomedical products and functional foods because of their significant biological functions, such as inhibiting tumor growth, triggering immunity, antioxidation, anti-virus and neuroprotection.

Recent studies indicated that polysaccharides extracted from higher plants showed anti-tumor activity by enhancing immunity. In addition to anti-tumor effect through immunomodulation, polysaccharides can directly inhibit tumor angiogenesis. Various polysaccharides, such as dandelion polysaccharide, sulfated polysaccharide, Fucoidan, LEP-2a, and Galactomannan, exert important roles in tumor angiogenesis Table 3.

Dandelion polysaccharide has been proved to inhibit angiogenesis both in vivo and in vitro. Sulfurized polysaccharide is derived from Phellinus ribis. Fucoidan is proved to reduce the expression of VEGF and PDGF in two chicken embryo chorioallantoic membrane CAM models Another important polysaccharide, Lep-2a, can restrain the expression of VEGF, CD, bFGF, MMP-2 and MMP-9 in hepatocellular carcinoma PSP is a galactomannan derived from the fruit rind of Punica granatum L.

A recent study found that galactomannan was able to suppress the expression of VEGF, MMP-2 and MMP-9 and up-regulate the expression of TIMP-1 and TIMP-2 in cancer cells Table 3 Natural anti-tumor angiogenesis polysaccharides and their sources, experimental models and anti-angiogenic mechanisms.

Alkaloids are a group of natural compounds with nitrogen structure and physiological function. Many alkaloids have complex nitrogen heterocyclic structures, and several compounds are organic amines with non-nitrogen heterocycles. Alkaloids have the properties of alkali, that are important active ingredients in Chinese herbal medicine.

Although certain vitamins, amino acids and peptides from natural sources are also nitrogenous compounds, they are not included in the category of alkaloids. Alkaloids are ubiquitous in nature, especially in the plant kingdom.

Alkaloids have been reported in at least species of plants, especially in Papaveraceae, tetrandridae, Solanaceae, Leguminosae, Apocynaceae, Ranunculaceae, and tillering family, et al.

The common alkaloids include pyrrole, pyridine, quinoline, isoquinoline, indole, imidazole, purine, anisodamine, terpenoids, steroids, organic amines, and so on and the chemical structures of these alkaloids are shown in Figure 4. Current studies proved the biological activities of alkaloids, including anti-tumor, anti-bacterial, anti-inflammatory, antiviral, antiarrhythmic, analgesic, and antispasmodic effects.

Voacangine is an indole-like compound, which is rich in Ervatamia Stapf. Treatment with voacangine decreases the VEGFR2 kinase activity in athymic nude mice bearing glioblastoma tumors and HUVECs, suggesting that its anti-angiogenic role is closely associated with VEGFR2 Evodiamine is an indoloquinazoline-like compound, which is derived from Euodia rutaecarpa Juss.

By inhibiting β-catenin, which reduces VEGF-A expression, Le Shi et al. found the anti-angiogenic role of evodiamine As an isocarbostyril compound, narciclasine regulates HUVECs proliferation by a RhoA-independent activation of the Rho kinase Rock Tetromethylpyrazine is an amide alkaloid, which is extracted from Ligusticum chuanxiong hort.

Previous studies found that harmine, a β-carboline alkaloid, suppressed bladder cancer growth by its anti-angiogenic effect, which was linked to VEGFR2 signaling pathway Oxysophocarpine is a quinolizidine alkaloid and it reduces the levels of HO-1, VEGF, MMP-9 and HIF-1 in OSCC cells Many alkaloids, such as chuanbeinone, halofuginone, tetrandrine, also play significant roles in tumor angiogenesis Table 4.

Figure 4 The chemical structures of alkaloids involved in tumor angiogenesis. Table 4 Natural anti-tumor angiogenesis alkaloids and their sources, experimental models and anti-angiogenic mechanisms. Terpenoids are natural products that derive from mevalonic acid.

Terpenoids are composed of multiple isoprene C5 units with the general formula of C 5 H 8 n. More than 20, terpenoids exist in nature and are widely distributed in the plant kingdom, such as Compositae, Ranunculaceae, Araliaceae, Oleaceae, Magnoliaceae, Lauraceae, Aristolochiaceae, and more.

Based on the different molecular structures Figure 5 , terpenoids are divided into five groups: monoterpenes, sesquiterpenes, diterpenoids, triterpenoids and terpenes compound. Most of the bioactive terpenoids have been isolated from medicinal plants.

For example, monoterpenes and sesquiterpenes are extracted from essential oils of medicinal plants and triterpenes are primarily available in balsams and resins. Recent studies have found that terpenoids have a variety of biological functions, including the regulation of enzyme system, cell surface signaling transduction, immune function, cell differentiation, tumor proliferation and angiogenesis.

Important terpenoids Perillyl Alcohol, β-elemene, Alantolactone, Tanshinone IIA, Triptolide, Ursolic acid, Koetjapic acid, et al and their molecular signaling pathways participate in modulating tumor angiogenesis Table 5. Perillyl Alcohol, hugely available in the essential oils of several plants Lavendin, Mints, Cherries, etc.

β-elemene is a sesquiterpene compound isolated from Curcuma Zedoaria. It inhibits the proliferation and metastasis of melanoma by suppressing VEGF-mediated angiogenesis Alantolactone is also a sesquiterpene compound extracted from Inula Helenium. Alantolactone inhibits angiogenesis by reducing the phosphorylation of VEGFR2 and its downstream protein kinases, including PLCγ1, FAK, Src, and Akt in breast cancer Tanshinone IIA is the key compound of Diterpene, isolated from Salvia Miltiorrhiza Bunge.

Tanshinone IIA has anti-angiogenic activity in human EPCs, which is associated with the regulation of VEGF, PLC, Akt and JNK signaling pathways Triptolide is also a Diterpene compound, derived from Tripterygium Wilfordii. As an important Triterpene compound, ursolic acid is able to decrease the expression of VEGF and iNOS in ehrlich ascites carcinoma Koetjapic acid is also a significant Triterpene compound.

Koetjapic acid is found to reduce the expression of VEGF in various angiogenic models, such as rat aortic ring, CAM and HUVECs Figure 5 The chemical structures of terpenoids involved in tumor angiogenesis. Table 5 Natural anti-tumor angiogenesis terpenoids and their sources, experimental models and anti-angiogenic mechanisms.

Saponins are composed of sapogenins and sugars. The sapogenins are triterpenes or spirostanes and the make-up sugars are commonly glucose, galactose, rhamnose, arabinose, xylose, glucuronic acid and galacturonic acid.

Lipophilic sapogenins and hydrophilic sugar chains make the saponin an excellent surfactant. Saponins are mainly distributed in terrestrial higher plants and marine organisms, such as starfish and sea cucumber. Many Chinese herbal medicines, such as Ginseng, Polygala Tenuifolia, Platycodon grandiflorum, licorice, Anemarrhena and Bupleurum , contain saponins as the main active ingredients.

According to the different structures of sapogenins, saponins have the biological functions of anti-tumor, hypoglycemic, cholesterol lowering, liver protection, immune regulation, anti-inflammatory and anti-microbial effects.

The chemical structures Figure 6 and anti-angiogenic property of several saponins Timosaponin AIII, Ginsenoside Rg3, β-Escin, sea cucumber saponins, et al has been identified in recent years Table 6.

Timosaponin AIII is a steroidal saponin, derived from Anemarrhena asphodeloides Bge. Ginsenoside Rg3 is a triterpene saponin, isolated from Panax ginseng.

Ginsenoside Rg3 can decrease the expression of MMP-2, MMP-9 and VEGF in B16 cell tumor mouse model and in vitro B16 cell model β-escin is also a kind of triterpene saponin, extracted from Aesculus hippocastanum seeds. β-escin can inhibit melanoma angiogenesis by increasing the expression of TIMP-1 and TIMP-2 Sea cucumber saponins are crude saponins, that are prevalent in Holothuria leucospilota.

The saponins extracted from sea cucumber can inhibit the expression of VEGF-D and TGF-β in MCF7 cells Figure 6 The chemical structures of saponins involved in tumor angiogenesis.

Table 6 Natural anti-tumor angiogenesis saponins and their sources, experimental models and anti-angiogenic mechanisms. This review article shed a light on the role of natural compounds in cancer therapy by modulating angiogenic factors and ECs apoptosis. In addition, the chemical structures of natural compounds involved in tumor angiogenesis were summarized and shown in supplementary material with the format of CS ChemDraw Drawing, which could be conveniently used for the related researchers.

Natural products have presented as new stars in the field of anti-tumor neovascularization research for their easy availability and cost-effectiveness A large number of epidemiological studies proved the reduction of cancer incidence upon the high nutritional ingestion of vegetables and fruits Currently, anti-angiogenic drugs are widely used and recognized in cancer treatments because they enriched the arsenal of chemotherapeutic drugs.

The majority of modern targeted drugs fail to achieve the expected therapeutic effects. Consequently, the anti-cancer regimens have shifted to multi-targeted therapies using traditional and integrative natural products. There is a huge number of natural products for anti-angiogenic substances and the study on the complex mechanisms of these compounds is just started.

Studies on the role of different structures of natural compounds in inhibiting tumor angiogenesis would assist in anti-cancer drug discovery and development. The anti-angiogenic therapy of human cancer patients is based on pre-clinical models that simulate the pathogenesis of human cancers, and most of them are elucidated in this review.

It is certain that future patients will be benefited from the novel discoveries of natural products, thus a lot of research works are warranted. As for clinical application of natural products in tumor, issues have emerged during the past few decades.

The bioavailability of natural products is the major restriction, since these compounds have the properties of poor aqueous solubility and low absorption rate.

Prior to the use of natural products in anti-tumor therapy, the concentration problem needs to be resolved. At present, several carriers nanoparticles, micelles, lipids, etc with natural products are being developed to apply to the delivery of these compounds to human body systems.

Therefore, as hopeful therapeutic targets towards tumor angiogenesis, more efforts should be made to the development of natural compounds and their modifiers according to their molecular mechanisms and involved signaling pathways in tumors.

PS, Z-SC, and DD conceived and designed the review. RL and XS created the tables and figures, and wrote the draft manuscript. RL, XS, and YG revised the manuscript and performed the table design.

PS, Z-SC, and DD reviewed and edited the manuscript. All authors read and approved the final manuscript. This work was supported by the National Natural Science Foundation of China ; the Gansu Province Science Foundation for Distinguished Young Scholars 20JR10RA and the Gansu Province Science Foundation for B Program RJZA from Gansu Provincial Sci.

Department; the Open Project of Research Center of Traditional Chinese Medicine, Gansu Province zyzxzx1 ; the Open Project of Key Laboratory of Prevention and Treatment for Chronic Diseases by TCM in Gansu Province GSMBKY ; the Gansu Province Health Industry Scientific Research Program Management Project GWGL ; and the National Natural Science Foundation of Shaanxi Province JQ The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers.

Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. Simon T, Gagliano T, Giamas G.

Direct Effects of Anti-Angiogenic Therapies on Tumor Cells: VEGF Signaling. Trends Mol Med 23 3 — doi: PubMed Abstract CrossRef Full Text Google Scholar. Haralambiev L, Neuffer O, Nitsch A, Kross NC, Bekeschus S, Hinz P, et al. Inhibition of Angiogenesis by Treatment With Cold Atmospheric Plasma as a Promising Therapeutic Approach in Oncology.

Int J Mol Sci 21 19 — CrossRef Full Text Google Scholar. Wang H, Yang J, Zhang K, Liu J, Li Y, Su W, et al. Front Pharmacol Chavakis E, Dimmeler S. Regulation of Endothelial Cell Survival and Apoptosis During Angiogenesis.

Arterioscler Thromb Vasc Biol 22 6 — Christensen SB. Natural Products That Changed Society. Biomedicines 9 5 — Deng J, Wang C, Jiang Y. Warming Yang Method in Traditional Chinese Medicine for Depression: A Protocol for Systematic Review and Meta-Analysis.

Med Baltimore 99 52 :e Sharma B, Dutt V, Kaur N, Mittal A, Dabur R. Tinospora Cordifolia Protects From Skeletal Muscle Atrophy by Alleviating Oxidative Stress and Inflammation Induced by Sciatic Denervation. J Ethnopharmacol Parveen A, Sultana R, Lee SM, Kim TH, Kim SY. Phytochemicals Against Anti-Diabetic Complications: Targeting the Advanced Glycation End Product Signaling Pathway.

Arch Pharm Res 44 4 — Gaikwad S, Srivastava SK. Role of Phytochemicals in Perturbation of Redox Homeostasis in Cancer. Antioxid Basel 10 1 — Fakhri S, Abbaszadeh F, Jorjani M, Pourgholami MH.

The Effects of Anticancer Medicinal Herbs on Vascular Endothelial Growth Factor Based on Pharmacological Aspects: A Review Study. Nutr Cancer 73 1 :1— Campos-Contreras ADR, Diaz-Munoz M, Vazquez-Cuevas FG. Purinergic Signaling in the Hallmarks of Cancer. Cells 9 7 — Parmar D, Apte M.

Angiopoietin Inhibitors: A Review on Targeting Tumor Angiogenesis. Eur J Pharmacol Jiang X, Wang J, Deng X, Xiong F, Zhang S, Gong Z, et al. The Role of Microenvironment in Tumor Angiogenesis. J Exp Clin Cancer Res 39 1 Cho WC, Jour G, Aung PP. Role of Angiogenesis in Melanoma Progression: Update on Key Angiogenic Mechanisms and Other Associated Components.

Semin Cancer Biol — Teleanu RI, Chircov C, Grumezescu AM, Teleanu DM. Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment. J Clin Med 9 1 — Wheler JJ, Janku F, Naing A, Li Y, Stephen B, Zinner R, et al. Mol Cancer Ther 15 10 — Ribatti D, Vacca A. Role of Endothelial Cells and Fibroblasts in Multiple Myeloma Angiogenic Switch.

Cancer Treat Res — Yoshida GJ, Azuma A, Miura Y, Orimo A. Activated Fibroblast Program Orchestrates Tumor Initiation and Progression; Molecular Mechanisms and the Associated Therapeutic Strategies. Int J Mol Sci 20 9 — Zhang Y, Liu NM, Wang Y, Youn JY, Cai H. Endothelial Cell Calpain as a Critical Modulator of Angiogenesis.

Biochim Biophys Acta Mol Basis Dis 6 — De Ieso ML, Yool AJ. Mechanisms of Aquaporin-Facilitated Cancer Invasion and Metastasis. Front Chem Liu G, Chen T, Ding Z, Wang Y, Wei Y, Wei X.

Inhibition of FGF-FGFR and VEGF-VEGFR Signalling in Cancer Treatment. Cell Prolif 54 4 :e Monk BJ, Poveda A, Vergote I, Raspagliesi F, Fujiwara K, Bae DS, et al. Anti-Angiopoietin Therapy With Trebananib for Recurrent Ovarian Cancer TRINOVA-1 : A Randomised, Multicentre, Double-Blind, Placebo-Controlled Phase 3 Trial.

Lancet Oncol 15 8 — Yang LI, Wang X, Sun J, Liu C, Li G, Zhu J, et al. Acta Biochim Biophys Sin Shanghai 53 6 — Gerber HP, Dixit V, Ferrara N. Vascular Endothelial Growth Factor Induces Expression of the Antiapoptotic Proteins Bcl-2 and A1 in Vascular Endothelial Cells.

J Biol Chem 21 —6. Control of Apoptosis During Angiogenesis by Survivin Expression in Endothelial Cells. Am J Pathol 2 —8. Kwak HJ, So JN, Lee SJ, Kim I, Koh GY. Angiopoietin-1 Is an Apoptosis Survival Factor for Endothelial Cells.

FEBS Lett — Carmeliet P, Lampugnani MG, Moons L, Breviario F, Compernolle V, Bono F, et al. Targeted Deficiency or Cytosolic Truncation of the VE-Cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis.

Cell 98 2 — Soldi R, Mitola S, Strasly M, Defilippi P, Tarone G, Bussolino F. Role of Alphavbeta3 Integrin in the Activation of Vascular Endothelial Growth Factor Receptor EMBO J 18 4 — Sha W, Liu M, Sun D, Qiu J, Xu B, Chen L, et al.

Resveratrol Improves Gly-LDL-Induced Vascular Endothelial Cell Apoptosis, Inflammatory Factor Secretion and Oxidative Stress by Regulating miRp and Regulating SPRED2-Mediated Autophagy. Aging Albany NY 13 5 — Vicas LG, Jurca T, Baldea I, Filip GA, Olteanu D, Clichici SV, et al.

Physalis Alkekengi L. Extract Reduces the Oxidative Stress, Inflammation and Apoptosis in Endothelial Vascular Cells Exposed to Hyperglycemia. Molecules 25 16 — Song P, Hai Y, Wang X, Zhao L, Chen B, Cui P, et al.

Realgar Transforming Solution Suppresses Angiogenesis and Tumor Growth by Inhibiting VEGF Receptor 2 Signaling in Vein Endothelial Cells. Arch Pharm Res 41 4 — Gordon E, Schimmel L, Frye M. The Importance of Mechanical Forces for In Vitro Endothelial Cell Biology. Front Physiol Victorelli FD, Cardoso VMO, Ferreira NN, Calixto GMF, Fontana CR, Baltazar F, et al.

Chick Embryo Chorioallantoic Membrane as a Suitable In Vivo Model to Evaluate Drug Delivery Systems for Cancer Treatment: A Review. Eur J Pharm Biopharm — Brown HK, Schiavone K, Tazzyman S, Heymann D, Chico TJ. Zebrafish Xenograft Models of Cancer and Metastasis for Drug Discovery.

Expert Opin Drug Discovery 12 4 — Auerbach R, Akhtar N, Lewis RL, Shinners BL. Angiogenesis Assays: Problems and Pitfalls. Cancer Metastasis Rev 19 — Croci DO, Cerliani JP, Dalotto-Moreno T, Méndez-Huergo SP, Mascanfroni ID, Dergan-Dylon S, et al.

Glycosylation-Dependent Lectin-Receptor Interactions Preserve Angiogenesis in Anti-VEGF Refractory Tumors. Cell 4 — Yu L, Wu X, Cheng Z, Lee CV, LeCouter J, Campa C, et al. Interaction Between Bevacizumab and Murine VEGF-A: A Reassessment. Invest Ophthalmol Vis Sci 49 2 —7.

Bonapace L, Coissieux MM, Wyckoff J, Mertz KD, Varga Z, Junt T, et al. Cessation of CCL2 Inhibition Accelerates Breast Cancer Metastasis by Promoting Angiogenesis. Nature —3. Kowshik J, Giri H, Kishore TK, Kesavan R, Vankudavath RN, Reddy GB, et al.

Anticancer Agents Med Chem 14 9 — Wang N, Wang ZY, Mo SL, Loo TY, Wang DM, Luo HB, et al. Ellagic Acid, a Phenolic Compound, Exerts Anti-Angiogenesis Effects via VEGFR-2 Signaling Pathway in Breast Cancer.

Breast Cancer Res Treat 3 — Park JJ, Hwang SJ, Park JH, Lee HJ. Cell Oncol Dordr 38 2 —8. McMaster Experts is powered by VIVO.

Toggle navigation. Home People Departments Research About Login. abstract An integrative approach for managing a patient with cancer should target the multiple biochemical and physiologic pathways that support tumour development and minimize normal-tissue toxicity.

Angiogenesis is a key process in the promotion of cancer. Many natural health products that inhibit angiogenesis also manifest other anticancer activities. The present article focuses on products that have a high degree of anti-angiogenic activity, but it also describes some of the many other actions of these agents that can inhibit tumour progression and reduce the risk of metastasis.

The herbs that are traditionally used for anticancer treatment and that are anti-angiogenic through multiple interdependent processes including effects on gene expression, signal processing, and enzyme activities include Artemisia annua Chinese wormwood , Viscum album European mistletoe , Curcuma longa curcumin , Scutellaria baicalensis Chinese skullcap , resveratrol and proanthocyanidin grape seed extract , Magnolia officinalis Chinese magnolia tree , Camellia sinensis green tea , Ginkgo biloba, quercetin, Poria cocos, Zingiber officinalis ginger , Panax ginseng, Rabdosia rubescens hora Rabdosia , and Chinese destagnation herbs.

Background: Optential, also known as angiogenesis, is the process of capillary sprouting from pre-existing blood vessels. This Anti-angiogenesis potential of natural compounds process Anti-angiigenesis a Anti-angiogeness event in Hydration and protein synthesis in sports embryonic Anti-angiogenesis potential of natural compounds as blood vessels generally Obesity and self-esteem both compoundds and Anti-angiogenesjs to the cells nayural the body. Any disruption in this process can lead to the development of various chronic diseases, including cancer. In cancer, aberrant angiogenesis plays a prominent role in maintaining sustained tumor growth to malignant phenotypes and promoting metastasis. The leakiness in the tumor microvasculature is attributed to the tumor cells migrating to distal site organs and forming colonies. Methods: In this article, we briefly review the various mediators involved in the angiogenic process and the anti-angiogenic potential of selected natural compounds against various malignancies. Thank you for vompounds nature. You Anti-angiogeneeis using Anti-angiogenesis potential of natural compounds compounrs version with limited support for Anti-angiogenesis potential of natural compounds. To obtain the best potenial, we recommend you use a more up to date Ribose and healthy aging or compoumds off compatibility mode in Internet Explorer. In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript. In the past decade, the success of angiogenesis inhibitors in clinical contexts has established the antiangiogenic strategy as an important part of cancer therapy. During that time period, we have discovered and reported 17 compounds that exert potent inhibition on angiogenesis. These compounds exhibit tremendous diversity in their sources, structures, targets and mechanisms.

Author: Kitaur

5 thoughts on “Anti-angiogenesis potential of natural compounds

Leave a comment

Yours email will be published. Important fields a marked *

Design by ThemesDNA.com